Report on efficacy and safety of shoulder arthroscopy in Spain

15

Jun 2018

AQuAS performed a systematic review of the literature, whose objective was to assess the efficacy and safety of this procedure. Studies with the most significant evidence, dating from 2004 and later, have been searched for in the following databases: National Health Service Economic Evaluation Database, Database of Abstracts, TRIP Database, National Health Service Evidence, National Health Service Centre for Reviews and Dissemination, Medline, Scopus, The Cochrane Library Plus, ISI Web of Knowledge and Reviews of Effects. More than 140 references have been screened (146 to be exact); one (1) clinical practice guideline, two (2) meta-analyses, 32 systematic reviews, seven (7) systematic reviews and meta-analysis, and one (1) RCT were selected.

Conclusion

The arthroscopic procedures have demonstrated effectiveness (in terms of functional scores and patient satisfaction) for the surgical treatment of anterior, posterior and multidirectional glenohumeral instability, rotator cuff lesions, arthroscopic acromioplasty, arthroscopic surgery of SLAP (Superior Labrum from Anterior to Posterior) lesions, glenohumeral arthritis and adhesive capsulitis. Despite, the results were not conclusive regarding the decrease in the rates of recurrence. To assess the intervention safety, the factors related to the development of glenohumeral chondrolysis, the most significant adverse effect of arthroscopy were evaluated. The development of this pathology has no association with any particular diagnosis; in fact, the main risk factors were the mechanical, thermic and chemical procedures used during the intervention.

See the full report in Spanish (with summary in English) here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

24

Feb 2022

On January 18, 2022, the Ministry of Health has awarded the Framework Agreement for the acquisition of 81 linear accelerators included in the High-End Technology Equipment Investment Plan. Furthermore, the National Institute of Health Management (INGESA) has also initiated the processing of the Framework Agreement that will facilitate the acquisition of the equipment in the fields of interventional cardiology, interventional vascular radiology, interventional neurovascular, digital brachytherapy, computed tomography, magnetic resonance imaging, PET-CT, SPECT-CT.

Read more

17

Feb 2022

Since 2019, several low-cost and simple procedures in Belgium have been reimbursed not via individual INAMI fees but APR-DRG groups. This funding system is called “Low Variability Care”. On January 26, 2022, the list of APR-DRG groups and corresponding reimbursement amounts for 2022 was published.

Read more

15

Feb 2022

In January 2022, the Basque Office for Health Technology Assessment (OSTEBA) released an HTA report aiming to assess and compare the efficacy, effectiveness, and safety of the mechanical circulatory support devices most used in the healthcare setting for the treatment and prevention of cardiogenic shock, including Impella® devices, intra-aortic balloon pumps, and extracorporeal membrane oxygenation.

Read more